Kinfo
Lipocine Inc. logo

Lipocine Inc.

LPCNNASDAQHealthcare·US · USD
$1.66
-0.06 (-3.49%)
Prices as of October 12, 2026 · market closed

Price

Key statistics

Valuation
Market cap14.18M USD
Enterprise value-8.83M USD
Trailing P/E-0.99
Forward P/E-1.39
PEG ratio0.05
Price / sales9.04
Price / book0.65
Profitability
Gross margin-973.86%
Operating margin-1495.14%
Profit margin-334.26%
Return on assets-37.04%
Return on equity-60.94%
Income (TTM)
Revenue1.57M USD
Gross profit1.57M USD
EBITDA-12.51M USD
Net income-11.85M USD
Diluted EPS-$1.85
Rev. growth (YoY)-69.50%
Balance sheet
Total cash23.27M USD
Total debt257.81K USD
Debt / equity1.18
Current ratio11.48
Book value / share$2.64
Cash flow (TTM)
Operating cash flow-11.19M USD
Levered free cash flow-6.94M USD
Shares & price
Shares outstanding8.24M
Float6.51M
Held by institutions36.19%
Beta0.40
50-day MA$2.15
200-day MA$4.36
52-week high$12.37
52-week low$1.72
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-04-0.40-0.32+20.00%2026-07-233.323.52+6.02%2026-05-07-0.48-0.54−12.50%2026-03-10-0.61-0.42+31.15%2025-11-06-0.54-0.59−9.26%
About Lipocine Inc.

Lipocine Inc. is a biopharmaceutical company focused on developing oral drug delivery products that improve the administration of therapies that are traditionally difficult to formulate. The company’s current portfolio includes TLANDO, an oral testosterone replacement therapy for men with low testosterone, and LPCN 1154 (BRLIZIO™), an oral neurosteroid under development for postpartum depression. Lipocine also advances additional product candidates across hormone-related, liver, and women’s health areas, using its proprietary delivery technology platform to support convenient oral dosing and differentiated therapeutic profiles. Based in Salt Lake City, Utah, Lipocine operates in the specialty pharmaceuticals and clinical-stage biotechnology markets, with its work centered on translating complex drug molecules into patient-friendly oral treatments.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Mahesh V. Patel Ph.D.
Employees
14
Headquarters
Salt Lake City, UT, United States

Frequently asked questions about Lipocine Inc.